Skip to content

Application of Transcutaneous Electrical Acupoint Stimulation Combined with Ultrasound-Guided Superior Laryngeal Nerve Block in Double-Lumen Endobronchial Intubation for Thoracic Surgery

Application of Transcutaneous Electrical Acupoint Stimulation Combined with Ultrasound-Guided Superior Laryngeal Nerve Block in Double-Lumen Endobronchial Intubation for Thoracic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112610
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic diseases with double-lumen bronchus tube

Interventions

Group C:General anesthesia alone
Group U:Ultrasound-guided bilateral superior laryngeal nerve blocks performed prior to anesthetic induction with regional anesthesia alone
T group:Transcutaneous electrical stimulation at bilateral PC6 (Neiguan), LI4 (Hegu), and CV22 (Tiantu) applied from 30 minutes before anesthetic induction until the end of surgery, using a sparse-den
TU group:On top of the U group, the TU group received transcutaneous electrical stimulation at bilateral PC6 (Neiguan), LI4 (Hegu), and CV22 (Tiantu) from 30 minutes before anesthetic induction until

Sponsors

The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age range: Age 18–65 years, BMI 18–30 kg/m^2, ASA I–III; 2. Patients undergoing thoracic surgery under general anesthesia with double-lumen endobronchial intubation; 3. Surgical duration < 3 hours; 4. Completed all preoperative auxiliary examinations and no history of immune system diseases; 5. Voluntarily participating in this study, having signed written informed consent, and willing to comply with follow-up.

Exclusion criteria

Exclusion criteria: Allergy to local anesthetic drugs, coagulation dysfunction, skin damage with infection at puncture site, severe cardiopulmonary, hepatic and renal insufficiency, and inability to cooperate with the investigator.

Design outcomes

Secondary

MeasureTime frame
Cardiovascular response;Detection of inflammatory and stress response indicators;Cough in patients after intubation;Visual analog score for sore throat;Oral suction response;Postoperative adverse reactions;

Primary

MeasureTime frame
Restlessness Score;

Countries

China

Contacts

Public ContactHe Qingbiao

The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

18565333211@163.com+86 185 6533 3211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026